• Xalatan

  Form: drops, ophthalmic solution

  Active substance	Dosage
  latanoprost	50 mcg/ml

  ATC code: S01EE01

  Manufacturer: Pfizer Manufacturing Belgium

• Xalcori

  Form: capsules

  Active substance	Dosage
  crizotinib	200 mg

  ATC code: L01ED01

  Manufacturer: Pfizer Manufacturing Deutschland GmbH

• Xalcori

  Form: capsules

  Active substance	Dosage
  crizotinib	250 mg

  ATC code: L01ED01

  Manufacturer: Pfizer Manufacturing Deutschland GmbH

• Xalo-pharm

  Form: drops, ophthalmic solution

  Active substance	Dosage
  latanoprost	0.05 mg/ml
  timolol	5 mg/ml

  ATC code: S01ED51

  Manufacturer: LLC "FARMEKS GROUP"

• Xaloptic

  Form: drops, ophthalmic solution

  Active substance	Dosage
  latanoprost	50 mcg/ml

  ATC code: S01EE01

  Manufacturer: Taejoon Pharm. Co. Ltd (manufacturing APIs, primary packaging, quality control)

• Xaloptic combo eco

  Form: drops, ophthalmic solution

  Active substance	Dosage
  latanoprost	50 mcg/ml
  timolol	5 mg/ml

  ATC code: S01ED51

  Manufacturer: Lomapharm GmbH (manufacturing, packaging, quality control and batch release of medicinal product)

• Xaloptic eco

  Form: drops, ophthalmic solution

  Active substance	Dosage
  latanoprost	50 mcg/ml

  ATC code: S01EE01

  Manufacturer: Lomapharm GmbH (manufacturing, packaging, quality control and batch release of medicinal product)

• Xaltophy®

  Form: solution for injection

  Active substance	Dosage
  insulin degludec	100 IU/ml
  liraglutide	3.6 mg/ml

  ATC code: A10AE56

  Manufacturer: A/S Novo Nordisk (manufacturer responsible for collection, labeling and secondary packaging of finished product, quality control of finished product; manufacturer of unpackaged product, filling, primary packaging, inspection and quality control, responsible for batch release of final product)

• Xanthinol nicotinate

  Form: solution for injection

  Active substance	Dosage
  xanthinol nicotinate	150 mg/ml

  ATC code: C04AD02

  Manufacturer: PJSC "Halychpharm"

• Xanthinol nicotinate

  Form: tablets

  Active substance	Dosage
  xanthinol nicotinate	150 mg

  ATC code: C04AD02

  Manufacturer: PJSC "Halychpharm"

• Xarelto

  Form: tablets, film-coated

  Active substance	Dosage
  rivaroxaban	2.5 mg

  ATC code: B01AF01

  Manufacturer: Bayer AG (for the entire manufacturing process)

• Xarelto

  Form: tablets, film-coated

  Active substance	Dosage
  rivaroxaban	20 mg

  ATC code: B01AF01

  Manufacturer: Bayer AG (manufacturing bulk products, primary packaging, secondary packaging, batch control, batch release)

• Xarelto

  Form: tablets, film-coated

  Active substance	Dosage
  rivaroxaban	15 mg

  ATC code: B01AF01

  Manufacturer: Bayer AG (manufacturing bulk products, primary packaging, secondary packaging, batch control, batch release)

• Xarelto

  Form: tablets, film-coated

  Active substance	Dosage
  rivaroxaban	10 mg

  ATC code: B01AF01

  Manufacturer: Bayer AG (Production of bulk products, primary packaging, secondary packaging, batch control, batch release)

• Xarelto

  Form: suspension, oral

  Active substance	Dosage
  rivaroxaban	1 mg/ml

  ATC code: B01AF01

  Manufacturer: Bayer AG (manufacturing in bulk, primary packaging, secondary packaging, quality control, batch release)

• Xavron

  Form: solution for injection

  Active substance	Dosage
  edaravone	1.5 mg/ml

  ATC code: N07XX14

  Manufacturer: Yuria-Pharm LLC

• Xefocam

  Form: tablets, film-coated

  Active substance	Dosage
  lornoxicam	8 mg

  ATC code: M01AC05

  Manufacturer: Takeda GmbH, manufacturing site Oranienburg

• Xefocam

  Form: tablets, film-coated

  Active substance	Dosage
  lornoxicam	4 mg

  ATC code: M01AC05

  Manufacturer: Takeda GmbH, manufacturing site Oranienburg

• Xefocam

  Form: powder for injection solution

  Active substance	Dosage
  lornoxicam	8 mg

  ATC code: M01AC05

  Manufacturer: Takeda Austria GmbH (secondary packaging and batch release)

• Xefocam® rapid

  Form: tablets, film-coated

  Active substance	Dosage
  lornoxicam	8 mg

  ATC code: M01AC05

  Manufacturer: Takeda GmbH, manufacturing site Oranienburg

• Xelaif

  Form: gas, compressed

  Active substance	Dosage
  xenon	not less than 99.999 %

  ATC code: N01AX15

  Manufacturer: INGAZ LLC

• Xeljanz

  Form: tablets, extended-release

  Active substance	Dosage
  tofacitinib	11 mg

  ATC code: L04AF01

  Manufacturer: Pfizer Manufacturing Deutschland GmbH (testing, packaging, batch release)

• Xeljanz

  Form: tablets, film-coated

  Active substance	Dosage
  tofacitinib	5 mg

  ATC code: L04AF01

  Manufacturer: Pfizer Manufacturing Deutschland GmbH (full-cycle manufacturing)

• Xeloda

  Form: tablets, film-coated

  Active substance	Dosage
  capecitabine	150 mg

  ATC code: L01BC06

  Manufacturer: Exella GmbH & Co. KG (Manufacturing with full cycle)

• Xeloda

  Form: tablets, film-coated

  Active substance	Dosage
  capecitabine	500 mg

  ATC code: L01BC06

  Manufacturer: Exella GmbH & Co. KG (Manufacturing with full cycle)

• Xenical®

  Form: capsules

  Active substance	Dosage
  orlistat	120 mg

  ATC code: A08AB01

  Manufacturer: Delpharm Milano S.R.L. (manufacturing of unpackaged products, primary and secondary packaging, quality control testing)

• Xenpoma

  Form: capsules, hard

  Active substance	Dosage
  pomalidomide	1 mg

  ATC code: L04AX06

  Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

• Xenpoma

  Form: capsules, hard

  Active substance	Dosage
  pomalidomide	2 mg

  ATC code: L04AX06

  Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

• Xenpoma

  Form: capsules, hard

  Active substance	Dosage
  pomalidomide	3 mg

  ATC code: L04AX06

  Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

• Xenpoma

  Form: capsules, hard

  Active substance	Dosage
  pomalidomide	4 mg

  ATC code: L04AX06

  Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

• Xenpozyme

  Form: powder for preparation of concentrate for infusion solution

  Active substance	Dosage
  olipudase alfa	20 mg

  ATC code: A16AB25

  Manufacturer: Genzyme Ireland Limited (manufacturing of the final product (filling, lyophilization), packaging, labeling, quality control and batch release, analytical testing of intermediate and finished medicinal products, stability testing, storage)

• Xeomin

  Form: powder for injection solution

  Active substance	Dosage
  botulinum toxin type A	50 LD50 units

  ATC code: M03AX01

  Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based quantification, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

• Xeomin

  Form: powder for injection solution

  Active substance	Dosage
  botulinum toxin type A	100 LD50 units

  ATC code: M03AX01

  Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based assay, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

• Xeplion®

  Form: suspension for injection, prolonged action

  Active substance	Dosage
  paliperidone	100 mg/ml

  ATC code: N05AX13

  Manufacturer: Janssen Pharmaceutica NV

• Xeroform

  Form: powder, topical

  Active substance	Dosage
  bismuth tribromophenolate	7 g or 10 g

  ATC code: D08AX

  Manufacturer: Istok-Plus LLC

• Xevulan

  Form: powder for injection solution or infusion solution

  Active substance	Dosage
  amoxicillin	1000 mg
  clavulanic acid	200 mg

  ATC code: J01CR02

  Manufacturer: ANTIBIOTICS SA

• Xgeva®

  Form: solution for injection

  Active substance	Dosage
  denosumab	70 mg/ml

  ATC code: M05BX04

  Manufacturer: Amgen Manufacturing Limited (manufacturer of unpackaged product, primary packaging)

• Xifaxan

  Form: tablets, film-coated

  Active substance	Dosage
  rifaximin	550 mg

  ATC code: A07AA11

  Manufacturer: Alfasigma S.p.A.

• Xigduo prolong

  Form: tablets, film-coated, prolonged release

  Active substance	Dosage
  dapagliflozin	10 mg
  metformin	1000 mg

  ATC code: A10BD15

  Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

• Xigduo prolong

  Form: tablets, film-coated, prolonged release

  Active substance	Dosage
  dapagliflozin	5 mg
  metformin	1000 mg

  ATC code: A10BD15

  Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

• Xigduo prolong

  Form: tablets, film-coated, prolonged release

  Active substance	Dosage
  dapagliflozin	10 mg
  metformin	500 mg

  ATC code: A10BD15

  Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

• Xinoksis®

  Form: tablets, film-coated

  Active substance	Dosage
  hydroxychloroquine	200 mg

  ATC code: P01BA02

  Manufacturer: Farmak JSC

• Xipogama

  Form: tablets

  Active substance	Dosage
  xipamide	10 mg

  ATC code: C03BA10

  Manufacturer: Artesan Pharma GmbH & Co. KG

• Xipogama®

  Form: tablets

  Active substance	Dosage
  xipamide	20 mg

  ATC code: C03BA10

  Manufacturer: Artesan Pharma GmbH & Co. KG

• Xipogama®

  Form: tablets

  Active substance	Dosage
  xipamide	40 mg

  ATC code: C03BA10

  Manufacturer: Artesan Pharma GmbH & Co. KG

• Xofluza

  Form: tablets, film-coated

  Active substance	Dosage
  baloxavir marboxil	20 mg

  ATC code: J05AX25

  Manufacturer: F. Hoffmann-La Roche Ltd (batch release of finished medicinal product; quality control testing for release and stability (excluding microbiological purity); quality control testing for release and stability (only microbiological purity))

• Xofluza

  Form: tablets, film-coated

  Active substance	Dosage
  baloxavir	40 mg

  ATC code: J05AX25

  Manufacturer: F. Hoffmann-La Roche Ltd (release of finished medicinal product; quality control testing upon release and stability (excluding microbiological purity), primary and secondary packaging, including in-process control, release of finished medicinal product; quality control testing upon release and stability (only microbiological purity))

• Xolar

  Form: powder for injection solution

  Active substance	Dosage
  omalizumab	150 mg

  ATC code: R03DX05

  Manufacturer: Novartis Pharma Stein AG

• Xolar

  Form: powder for injection solution

  Active substance	Dosage
  omalizumab	75 mg

  ATC code: R03DX05

  Manufacturer: Novartis Pharma Stein AG

• Xolar

  Form: solution for injection

  Active substance	Dosage
  omalizumab	75 mg/0.5 ml

  ATC code: R03DX05

  Manufacturer: Novartis Pharma GmbH (Batch release)